VAM
IDIX

Visium Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Visium Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-92,800
Closed -$2K – 1378
2014
Q2 		$2K Buy
+92,800
New +$967K ﹤0.01% 1085

Visium Asset Management's IDIX Position: Q4 2013 in Review

Visium Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q4 2013, closing a stake of 1,307,132 shares — an estimated $6.81M sold.

Visium Asset Management first reported a position in IDIX in Q2 2013 and held it in 2 quarters. The position peaked at $6.81M in Q3 2013. 88 funds tracked by Wall St. Rank hold IDIX as of Q4 2013.

  • Visium Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Visium Asset Management sold 1,307,132 IDENIX PHARMACEUTICALS INC shares in Q4 2013, an estimated $6.81M.
  • Visium Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Visium Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $6.81M in Q3 2013.
  • 88 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q4 2013.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.